Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 2,053 | 5,639 | 4,548 | 4,822 | 4,593 |
| Gross Profit | 2,050 | 5,630 | 4,550 | 4,820 | 4,590 |
| Operating Expenses | 5,750 | 5,870 | 7,980 | 9,010 | 10,010 |
| Operating Income | -3,697 | -231 | -3,432 | -4,188 | -5,417 |
| Interest Expense | 360 | 360 | 440 | 420 | 300 |
| Other Income | -2,853 | -239 | -2,228 | -222 | -713 |
| Pre-tax Income | -6,910 | -830 | -6,100 | -4,830 | -6,430 |
| Net Income Continuous | -6,915 | -830 | -6,090 | -4,834 | -6,437 |
| Net Income | $-6,915 | $-830 | $-6,090 | $-4,834 | $-6,437 |
| EPS Basic Total Ops | -9,103.64 | -1,400.56 | -8,403.36 | -7,703.08 | -10,504.20 |
| EPS Basic Continuous Ops | -9,878.57 | -1,185.71 | -8,700.00 | -8,056.67 | -10,728.33 |
| EPS Diluted Total Ops | -9,103.64 | -1,400.56 | -8,403.36 | -7,703.08 | -10,504.20 |
| EPS Diluted Continuous Ops | -9,878.57 | -1,185.71 | -8,700.00 | -8,056.67 | -10,728.33 |
| EBITDA(a) | $-2,927 | $539 | $-2,622 | $-3,248 | $-4,517 |